Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration.
Hiatt
William R
WR
University of Colorado Denver, School of Medicine, Denver, CO 80203, USA. will.hiatt@uchsc.edu
Lincoff
A Michael
AM
Harrington
Robert A
RA
D026683:Advisory Committees; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000889:Anti-Arrhythmia Agents